Anthony L. DeVico

11.6k total citations · 2 hit papers
105 papers, 7.2k citations indexed

About

Anthony L. DeVico is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Anthony L. DeVico has authored 105 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Virology, 77 papers in Immunology and 29 papers in Infectious Diseases. Recurrent topics in Anthony L. DeVico's work include HIV Research and Treatment (89 papers), Immune Cell Function and Interaction (57 papers) and Monoclonal and Polyclonal Antibodies Research (26 papers). Anthony L. DeVico is often cited by papers focused on HIV Research and Treatment (89 papers), Immune Cell Function and Interaction (57 papers) and Monoclonal and Polyclonal Antibodies Research (26 papers). Anthony L. DeVico collaborates with scholars based in United States, Nigeria and Italy. Anthony L. DeVico's co-authors include Robert C. Gallo, Alfredo Garzino‐Demo, Paolo Lusso, Fiorenza Cocchi, Suresh K. Arya, George K. Lewis, Terry D. Copeland, Stephen Oroszlan, M. G. Sarngadharan and Fulvia Veronese and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Anthony L. DeVico

104 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 ⁺ T Cells

1995 2.4k citations Anthony L. DeVico, Robert C. Gallo et al. profile →
Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAV

1986 487 citations Fulvia Veronese, Terry D. Copeland et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anthony L. DeVico United States	37	5.2k	3.9k	2.4k	1.4k	1.3k	105	7.2k
Tatjana Dragic United States	34	5.5k 1.1×	4.0k 1.0×	2.4k 1.0×	1.7k 1.2×	1.6k 1.3×	44	8.0k
James Arthos United States	45	5.5k 1.1×	4.9k 1.3×	2.1k 0.9×	1.9k 1.3×	1.5k 1.2×	113	8.4k
Yaoxing Huang United States	38	4.9k 0.9×	4.2k 1.1×	4.2k 1.7×	1.9k 1.4×	1.3k 1.0×	84	9.1k
Sunny Choe United States	10	6.5k 1.3×	4.6k 1.2×	2.9k 1.2×	1.7k 1.2×	1.3k 1.0×	10	8.4k
Frances Gotch United Kingdom	39	3.6k 0.7×	5.3k 1.4×	1.7k 0.7×	1.6k 1.1×	2.6k 2.1×	131	8.5k
Benjamin J. Doranz United States	48	4.2k 0.8×	4.1k 1.0×	3.5k 1.5×	2.0k 1.4×	1.4k 1.1×	104	9.2k
William A. Paxton Netherlands	36	7.9k 1.5×	5.8k 1.5×	3.6k 1.5×	1.8k 1.3×	1.6k 1.3×	88	10.3k
Jesus F. Salazar-Gonzalez United States	20	3.9k 0.7×	2.1k 0.5×	2.0k 0.8×	1.0k 0.7×	1.1k 0.9×	36	5.1k
Marc Alizon France	36	4.7k 0.9×	2.5k 0.6×	2.4k 1.0×	1.7k 1.2×	1.6k 1.3×	59	6.5k
Ruth M. Ruprecht United States	43	4.3k 0.8×	2.5k 0.6×	2.1k 0.9×	1.4k 1.0×	1.8k 1.4×	179	6.6k

Countries citing papers authored by Anthony L. DeVico

Since Specialization

Citations

This map shows the geographic impact of Anthony L. DeVico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony L. DeVico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony L. DeVico more than expected).

Fields of papers citing papers by Anthony L. DeVico

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony L. DeVico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony L. DeVico. The network helps show where Anthony L. DeVico may publish in the future.

Co-authorship network of co-authors of Anthony L. DeVico

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony L. DeVico. A scholar is included among the top collaborators of Anthony L. DeVico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony L. DeVico. Anthony L. DeVico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tagaya, Yutaka, et al.. (2022). Identifying CCR5 coreceptor populations permissive for HIV-1 entry and productive infection: implications for in vivo studies. Journal of Translational Medicine. 20(1). 39–39. 10 indexed citations

Liu, Qingbo, Peng Zhang, Huiyi Miao, et al.. (2021). Rational Engraftment of Quaternary-Interactive Acidic Loops for Anti-HIV-1 Antibody Improvement. Journal of Virology. 95(12). 4 indexed citations

Tehrani, Zahra Rikhtegaran, Saman Saadat, Xin Ouyang, et al.. (2020). Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays. PLoS ONE. 15(11). e0237828–e0237828. 54 indexed citations

Agrawal, Parul, Anthony L. DeVico, James S. Foulke, et al.. (2019). Stoichiometric Analyses of Soluble CD4 to Native-like HIV-1 Envelope by Single-Molecule Fluorescence Spectroscopy. Cell Reports. 29(1). 176–186.e4. 8 indexed citations

Lewis, George K., Anthony L. DeVico, & Robert C. Gallo. (2014). Antibody persistence and T-cell balance: Two key factors confronting HIV vaccine development. Proceedings of the National Academy of Sciences. 111(44). 15614–15621. 59 indexed citations

Thomas, Michael A., Iskra Tuero, Thorsten Demberg, et al.. (2014). HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaques. Virology. 471-473. 81–92. 20 indexed citations

Sajadi, Mohammad M., George K. Lewis, Michael S. Seaman, et al.. (2012). Signature Biochemical Properties of Broadly Cross-Reactive HIV-1 Neutralizing Antibodies in Human Plasma. Journal of Virology. 86(9). 5014–5025. 11 indexed citations

Sajadi, Mohammad M., Yongjun Guan, Anthony L. DeVico, et al.. (2011). Correlation Between Circulating HIV-1 RNA and Broad HIV-1 Neutralizing Antibody Activity. JAIDS Journal of Acquired Immune Deficiency Syndromes. 57(1). 9–15. 32 indexed citations

DeVico, Anthony L., Timothy Fouts, George K. Lewis, et al.. (2007). Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens. Proceedings of the National Academy of Sciences. 104(44). 17477–17482. 65 indexed citations

10.

Fouts, Timothy, et al.. (2006). An Immunoglobulin Fusion Protein Based on the gp120-CD4 Receptor Complex Potently Inhibits Human Immunodeficiency Virus Type 1 in Vitro. AIDS Research and Human Retroviruses. 22(6). 477–490. 9 indexed citations

11.

DeVico, Anthony L., et al.. (2005). Analogues of N-terminal truncated synthetic peptide fragments derived from RANTES inhibit HIV-1 infectivity. Bioorganic & Medicinal Chemistry Letters. 16(1). 93–95. 4 indexed citations

12.

DeVico, Anthony L., et al.. (1996). Covalently Crosslinked Complexes of Human Immunodeficiency Virus Type 1 (HIV-1) gp120 and CD4 Receptor Elicit a Neutralizing Immune Response That Includes Antibodies Selective for Primary Virus Isolates. Virology. 218(1). 258–263. 37 indexed citations

13.

DeVico, Anthony L., Rukhsana Rahman, M. G. Sarngadharan, & Fulvia Veronese. (1994). Mechanism of Enzyme Inhibition Mediated by Anti-Reverse Transcriptase Antibodies from HIV Type 1-Infected Individuals. AIDS Research and Human Retroviruses. 10(8). 953–960. 3 indexed citations

14.

DeVico, Anthony L., et al.. (1993). High Prevalence of Serum Antibodies to Equine Infectious Anemia Virus Reverse Transcriptase. AIDS Research and Human Retroviruses. 9(1). 7–11. 3 indexed citations

15.

Pal, Ranajit, Anthony L. DeVico, Stephen Rittenhouse, & M. G. Sarngadharan. (1993). Conformational Perturbation of the Envelope Glycoprotein gp120 of Human Immunodeficiency Virus Type 1 by Soluble CD4 and the Lectin Succinyl Con A. Virology. 194(2). 833–837. 9 indexed citations

16.

DeVico, Anthony L., et al.. (1991). Purification and partial characterization of equine infectious anemia virus reverse transcriptase. Virology. 185(1). 387–394. 20 indexed citations

17.

Stein, Christian, Ranajit Pal, Anthony L. DeVico, et al.. (1991). Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro. Biochemistry. 30(9). 2439–2444. 69 indexed citations

18.

Kalyanaraman, Vaniambadi S., Fulvia Veronese, Rukhsana Rahman, et al.. (1990). Characterization of the Secreted, Native gp120 and gp160 of the Human Immunodeficiency Virus Type 1. AIDS Research and Human Retroviruses. 6(3). 371–380. 70 indexed citations

19.

DeVico, Anthony L., Terry D. Copeland, Fulvia Veronese, et al.. (1989). Purification and Partial Characterization of Human Immunodeficiency Virus Type 2 Reverse Transcriptase. AIDS Research and Human Retroviruses. 5(1). 51–60. 27 indexed citations

20.

DeVico, Anthony L., Fulvia Veronese, Stephanie L. Lee, Robert C. Gallo, & M. G. Sarngadharan. (1988). High Prevalence of Serum Antibodies to Reverse Transcriptase in HIV-1-Infected Individuals. AIDS Research and Human Retroviruses. 4(1). 17–22. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact